Pittsburgh, PA, United States of America

John Alston Kellum

This inventor holds 26 USPTO granted patents and 11 published patent applications, plus 2 CIPO patents and 8 EPO patents, primarily in Biomarker Discovery. Top assignees: University of Pittsburgh, Astute Medical, Inc., Duquesne University. Active years: 2013-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Alston Kellum. Retrieved from https://idiyas.com/inventor/john-alston-kellum

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 (Patent Applications = 11)

% Patents Active = 96.2

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 13)

Average Co-Inventor Count = 2.6

ph-index = 3

Forward Citations = 72(Granted Patents)

Location History:

Pittsburg, PA (US) (2017 - 2018)
Pittsburgh, PA (US) (2013 - 2023)

Company Filing History:

25 out of 1,960

University of Pittsburgh

Westfalische Wilhelms-Universität Münster

patents

where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...

Areas of Expertise:

Biomarkers

Renal Injury

Sepsis

Organ Function

Bacteriophage Detection

Metabolomics

Dialysis

Proteomics

Inflammation Treatment

Cell Modification

Acute Kidney Injury

Sorbent Polymer

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12259397 - Biomarkers related to organ function (2025-03-25),

2. 11747342 - Proteomic biomarkers of sepsis in young patients (2023-09-05),

3. 11693014 - Biomarkers of renal injury (2023-07-04),

4. 11629370 - Detection of bacteria using bacteriophage (2023-04-18),

5. 11243217 - Management of acute kidney injury using insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2 (2022-02-08),

6. 11243202 - Methods and compositions for diagnosis and prognosis of renal injury and renal failure (2022-02-08),

7. 11229676 - Methods and compositions for diagnosis and prognosis of renal injury and renal failure (2022-01-25),

8. 10961557 - Detection of bacteria using bacteriophage (2021-03-30),

9. 10948497 - Proteomic biomarkers of sepsis in elderly patients (2021-03-16),

10. 10634686 - Biomarkers related to organ function (2020-04-28),

11. 10557856 - Biomarkers of renal injury (2020-02-11),

12. 10544443 - Detection of bacteria using bacteriophage (2020-01-28),

13. 10533989 - Metabolomics in pneumonia and sepsis (2020-01-14),

14. 10322221 - Removal of carbon dioxide via dialysis (2019-06-18),

15. 10300108 - Methods and compositions for diagnosis and prognosis of renal injury and renal failure (2019-05-28),

Title: The Innovative Journey of John Alston Kellum

Introduction:

John Alston Kellum, a pioneering inventor hailing from Pittsburgh, PA, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents:

Kellum's latest patents include a revolutionary smart home device that integrates artificial intelligence for enhanced security and convenience, as well as a sustainable energy solution that aims to reduce carbon footprint in residential areas.

Career Highlights:

With a career spanning over two decades, Kellum has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has been recognized with multiple awards and accolades in the field of technology and engineering.

Collaborations:

Throughout his career, Kellum has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has led to the successful commercialization of several groundbreaking technologies.

Conclusion:

In conclusion, John Alston Kellum's relentless pursuit of innovation and his passion for creating technology-driven solutions have cemented his legacy as a trailblazing inventor in the ever-evolving landscape of technological advancements.

Profile summary based on public USPTO records.